This site is optimised for modern browsers. For the best experience, please use Google Chrome, Mozilla Firefox, or Microsoft Edge.
The Invention for Innovation (i4i) programme is a translational research funding scheme aimed at de-risking early-to-late stage medical devices, in vitro diagnostics and high-impact patient-focused digital health technologies for ultimate NHS use.
We fund projects that have demonstrated proof-of-concept and have a clear pathway towards adoption and commercialisation.
i4i has three funding streams: Product Development Awards (PDA), Challenge Awards and Connect. PDA and Challenge run two funding competitions a year, launching in autumn and spring, whereas Connect runs one funding competition each summer. See the full dates for i4i funding competitions. All i4i funding streams have a two stage application process.
|Funding stream||Autumn/Winter competition launch||Spring/Summer competition launch|
|Product Development Awards||October||April|
If you have a specific query regarding the eligibility of your planned study, please submit a pre-submission engagement form. Please note, the turnaround time for a response is 72 hours.
i4i Product Development Awards (PDA) support translational research and development of medical devices, in vitro diagnostics and high-impact patient-focused digital health technologies for ultimate NHS use. The research proposals may address any disease or health area, provided there is a clear unmet clinical need. There is no upper funding limit for Product Development Awards, but costs must be fully justified.
The NIHR i4i team hosted a webinar on Monday 12 April to answer questions from prospective applicants. If you would like to get in touch with one of the team, please email email@example.com.
|Competition 22||Stage 1||Stage 2|
|Webinar||12 April 2021 (2-3pm)||TBC|
|Competition launch||14 April 2021||10 August 2021|
|Submission deadline||9 June 2021 (1pm)||28 September 2021 (1pm)|
|Submission outcome||10 August 2021||December 2021|
Additionally, the i4i funding programme is participating in the 2021 NIHR Highlight Notice on Dementia research to address important health and social care questions. For more information please see the 2021 NIHR Highlight Notice on Dementia specification document.
In PDA Competition 21, we partnered with the Engineering and Physical Sciences Research Council (EPSRC), Asthma UK and the British Lung Foundation to highlight our support for the development and adoption of asthma health technologies. All disease areas will continue to be eligible for PDA 21 in the normal way. However, successful asthma-related projects will be co-funded through the Asthma Health Technology Fund partnership. Read the brief for the Asthma Health Technology fund.
|Competition 21||Stage 1||Stage 2|
|Webinars||8 and 14 October 2020||1 March 2021 (by invitation only)|
|Competition launch||20 October 2020||18 February 2021|
|Submission deadline||9 December 2020 (1pm)||14 April 2021 (1pm)|
|Submission outcome||18 February 2021||July 2021|
For an overview of the PDA competition 21, please watch the recording of our applicant webinar. If you would like a copy of the PowerPoint slides presented at the webinar, please email firstname.lastname@example.org.
i4i Challenge Awards support market-ready innovations by addressing the translational gap between the clinical evaluation of technologies and their adoption, by funding the assessment of MedTech innovations in real-world healthcare settings. The expected output is a disruptive medical device or in vitro diagnostic test that can offer improved outcomes for NHS patients. There is no upper funding limit for the Challenge Awards, but costs must be fully justified.
An Expert Panel discussion Webinar on Stimulating Collaborations for MedTech Real World Testing, took place on 7 April 2021, 11am-12pm.
The NIHR i4i Challenge Award in Real World Implementation webinar took place on Wednesday 14 April, 11am-12pm.
If you would like a copy of the PowerPoint slides presented at either of these webinars, please email email@example.com.
|Competition 12||Stage 1||Stage 2|
|Webinar||14 April 2021 (11am-12pm)||TBC|
|Competition launch||14 April 2021||4 August 2021|
|Submission deadline||10 June 2021||22 September 2021|
|Submission outcome||4 August 2021||December 2021|
For Challenge competition 11, we are partnering with the Engineering and Physical Sciences Research Council (EPSRC), Asthma UK and the British Lung Foundation to highlight our support for the development and adoption of asthma health technologies.
All disease areas will continue to be eligible for Challenge 11 in the normal way. However, successful asthma-related projects, will be co-funded through the Asthma Health Technology Fund partnership. Read the full brief for the Asthma Health Technology fund.
|Competition 11||Stage 1||Stage 2|
|Competition launch||4 November 2020||25 March 2021|
|Submission deadline||12 January 2021||5 May 2021|
|Submission outcome||25 March 2021||July 2021|
Additionally, the i4i funding programme is participating in the 2020 NIHR Themed Call on injuries, accidents and urgent and emergency care. For more information please see the themed call specification document on the themed calls webpage.
i4i Connect is aimed at small-to-medium-sized enterprises (SMEs) developing medical devices, in vitro diagnostics and Tier C digital health technologies with direct patient benefits, looking to ultimately integrate into the NHS. The funding stream aims to help SMEs reach the next stage in the development pathway to apply for further funding, in particular for an i4i Product Development Award. i4i Connect is researcher-led and does not specify topics for research.
The next Connect competition will be competition 5. It will include a separate funding stream for the Digital Health Technologies for Children and Young People’s Mental Health (CYPMH). This has different eligibility criteria and you cannot submit applications to both streams. Read the full details on how to apply for the CYPMH stream.
|Competition 5 and CYPMH||Stage 1||Stage 2|
|Competition launch||17 August 2021||6 October 2021|
|Submission deadline||14 September 2021||2 November 2021|
|Submission outcome||October 2021||November 2021|
i4i funding committees are multidisciplinary, comprising academic, clinical and commercial experts, as well as patient and public members.
We have four committees: two for our Product Development Awards (committee A and committee B), one for our Challenge Awards, and one for Connect.
Committee members review all Stage 1 and Stage 2 applications and make funding recommendations based on the quality of applications, with support from expert peer reviewers.
The committees recommend projects for funding to the Department of Health and Social Care, which approves which projects should be funded.
Members of NIHR committees are required to declare any interests which conflict, or may be considered to conflict, with NIHR business, or may be perceived as influencing decisions made in the course of their work within NIHR programmes. All members are asked to complete the Register of Interest form (annually), which is intended to capture long term predictable interests that could be perceived to lead to conflicts of interest. These and other interests are judged on a case by case basis at individual meetings.
The Product Development Awards Selection Committee A is chaired by Mr Mark Kirby. View the full membership of Selection Committee A.
The Product Development Awards Selection Committee B is chaired by Mr Charles Spicer. View the full membership of Selection Committee B.
The Selection Committee for the Challenge Awards is chaired by Professor Nick Lemoine. View the full membership of the Challenge Awards 2019 Selection Committee.
The Selection Committee for i4i Connect is chaired by Professor Paul Sibbons. View the full membership of the Connect Selection Committee.
We offer a wide variety of assistance during all stages of the research process. If in doubt, please get in touch.
Tel: 020 8843 8080
Our operating hours are 9.00am to 5.00pm
Director of Innovation Programmes and Head of Intellectual Property
Mr Ben Patient
Dr Ruth Nebauer
Head of Special Projects
Dr Ian Newington
Senior Programme Managers
Dr Sandra Nwokeoha (i4i lead)
Dr Andrew Barber
Dr Fanny Burrows
Dr Sultana Choudhry
Dr Caterina Lombardo
Mrs Paula Milton
Dr Raffaella Roncone
Dr Michelle Edye
Mr Edwin Tucker
Ms Rhanda Tajdeen
Dr Xi Ye
Dr Aayesha Hassan
Ms Deimante Normantaite
Senior Research Officers
Mr Bryan Dar
Ms Cordelia Davey
Ms Tanya Dixey
Ms Harkerat Jandu
NIHR Central Commissioning Facility
15 Church Street
Twickenham TW1 3NL
This document provides guidance for applicants completing an Expression of Interest form for the NIHR Invention for Innovation (i4i) Digital Health Technologies for Children and Young People’s Mental Health call.
This document provides an example of a standard NIHR research contract between the Secretary of State for Health and Social Care and an NHS Trust.
This document provides an example of a standard research contract between Secretary of State for Health and Social Care and a commercial organisation, such as a life sciences company.
This document provides an example of a standard research contract between Secretary of State for Health and Social Care and a higher education institution (HEI).
This document provides answers to questions frequently asked at the Q&A drop in session for prospective applicants on 08 April 2021.